The study of primary immunodeficiency diseases in man has provided much information on the development and maturation of the human immune system.
The study of primary immunodeficiency diseases in man has provided much information on the development and maturation of the human immune system. The discovery of monoclonal antisera that recognise different subpopulations of immature and mature lymphocytes has allowed better analysis. This may prove useful in increasing understanding of the immune system and will allow more logical classification of immunodeficiency disorders. Analysis of lymphocyte subpopulations by monoclonal antisera has recently been applied to the prenatal diagnosis of severe combined immunodeficiency.1
We report data on circulating lymphocyte subpopulations analysed by monoclonal antisera in 42 children with primary immunodeficiencies affecting either cell mediated immunity or humoral immunity or both. Samples from controls matched for age were analysed.
Methods
Patients and controls. Blood was taken from healthy children aged 8 months to 11 years who were being tested before minor cold surgical procedures, such as hernia repairs, but not including conditions where immunopathology might exist-for example, tonsillectomies. Younger controls were healthy term neonates tested in the first week of life.
The 42 patients studied had primary immunodeficiency as defined by WHO criteria.2 Six children with cartilage hair hypoplasia syndrome were included in the study, as primary immunodeficiency is believed to be a feature of this syndrome.3 At the time of testing none of the patients, apart from those with X-linked agammaglobulinaemia who were receiving intramuscular gammaglobulin, were receiving or had received any treatment likely to affect the immune system. Five patients were studied after treatment with the synthetic thymic hormone TP5 (Ortho Pharmaceuticals) (0-25-1 mg/kg, 3 times a week, subcutaneously). All tests on control and immunodeficient children were performed with the approval of the hospital ethical committees.
In all the patients and in the older group of controls mononuclear cell preparations from blood were prepared by Ficoll Hypaque (Lymphoprep Flow Laboratories) density centrifugation. In the term neonates total leucocyte preparations were made by Hetastarch sedimentation,4 which allows analysis of small quantities of blood. In 8 of the older children both methods of separation were tested in parallel. The ratios of the various subpopulations to each other were very similar by both methods, though the percentage values obtained for individual populations were, of course, lower in the Hetastarch separated preparations.
T cell percentages were counted by sheep cell rosetting (E rosetting, using neuraminidase treated sheep red cells).5 B cell numbers were estimated by direct immunofluorescence using a polyvalent antihuman immunoglobulin.6 Monoclonal antibody staining was performed by incubating the mononuclear cells with the particular monoclonal antibody and then washing extensively with a fluoresceinated sheep antimouse antibody. Cells were counted either by fluorescence microscopy or by flow fluorocytometery (FACS IV). In a proportion of cases both methods of analysis were used and gave comparable results. B cell numbers were estimated by fluorescence microscopy only.
The Children with X-linked agammaglobulinaemia with no circulating B cells showed OKT4:8 ratios in the normal range. Common variable hypogammaglobulinaemia is a heterogeneous condition confirmed by the wide scatter of OKT4:8 ratios that we found. One child with a very high OKT4:8 ratio has suffered from a variety of autoimmune problems (uveitis, arthritis, immune thrombocytopenia). Though her relative lack of suppressor cells might explain these problems, it is difficult to explain her IgG and IgA deficiency. In case 28 a very low OKT4:8 ratio was found, but we cannot claim this as the sole cause of her hypogammaglobulinaemia because she was chronically infected with adenovirus and it is known that virus infections can result in a low ratio. 16 The data on the patients studied after TP5 treatment indicate that this thymic hormone preparation has biological activity in vivo and is capable of inducing the appearance on T cells of differentiation markers. In the SCID and common variable hypogammaglobulinaemia patients, however, it was not of therapeutic benefit since the immune function was not improved.
Our analysis of lymphocyte subpopulations by the monoclonal antisera currently available has not provided a better classification of primary immunodeficiency diseases, but as more reagents that recognise better defined cell populations become available so improvements in diagnosis may arise. The major advance to date using these monoclonal reagents has been the ability to provide prenatal diagnosis for all varieties of severe combined immunodeficiency and this has now been achieved 
